pfizer filed an application this week to the US fda registration agency for approval of the comirnata vaccine for children 0.6-4 years in a 3-dose 3ug dose regimen. We are waiting for the assessment and decision of the regulator in the USA - most importantly, that the process of evaluating the test results has started